XML 47 R37.htm IDEA: XBRL DOCUMENT
v3.25.3

Segment Data (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting [Abstract] |
Schedule of Significant Segment Expenses | The Company has identified the following significant segment expenses (SSEs) due to their relevance to the overall consolidated operating results (in thousands):
| Three months ended September 30, |  | Nine months ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Net sales from external customers | $ | 154,558 |  |  | $ | 145,165 |  |  | $ | 453,882 |  |  | $ | 360,351 |
Significant segment expenses: |  |  |  |  |  |  |
Materials | 62,581 |  |  | 61,503 |  |  | 186,457 |  |  | 157,946 |
Salaries and Benefits | 46,984 |  |  | 38,936 |  |  | 133,857 |  |  | 94,122 |
Depreciation and amortization | 4,874 |  |  | 4,027 |  |  | 14,227 |  |  | 10,058 |
Interest expense, net | 2,393 |  |  | 3,475 |  |  | 7,873 |  |  | 4,683 |
Other segment items (a) | 16,662 |  |  | 16,005 |  |  | 48,497 |  |  | 39,616 |
Income before income tax provision | 21,064 |  |  | 21,219 |  |  | 62,971 |  |  | 53,926 |
Income tax provision | 4,681 |  |  | 4,858 |  |  | 12,224 |  |  | 11,320 |
Segment net income | $ | 16,383 |  |  | $ | 16,361 |  |  | $ | 50,747 |  |  | $ | 42,606 |
Segment total assets (b) | $ | 652,821 |  |  |  |  |  |  |
(a)Other segment items include (production overhead, stock compensation, professional fees, and other SG&A expenses). (b)See Condensed Consolidated Balance Sheet for details.
Schedule of Revenue by Major Customers by Reporting Segments | The Company’s products are primarily sold to customers within the Medical and Non-medical markets. Sales by market for the three and nine months ended September 30, 2025 and 2024 are as follows (in thousands):
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
|  | 2025 |  | 2024 (a) |  | 2025 |  | 2024 (a)
Market |  | Net Sales |  | % |  | Net Sales |  | % |  | Net Sales |  | % |  | Net Sales |  | %
Medical |  | $ | 142,358 |  |  | 92.1% |  | $ | 132,623 |  |  | 91.4% |  | $ | 417,107 |  |  | 91.9% |  | $ | 318,079 |  |  | 88.3%
Non-medical |  | 12,200 |  |  | 7.9% |  | 12,542 |  |  | 8.6% |  | 36,775 |  |  | 8.1% |  | 42,272 |  |  | 11.7%
Net Sales |  | $ | 154,558 |  |  | 100.0% |  | $ | 145,165 |  |  | 100.0% |  | $ | 453,882 |  |  | 100.0% |  | $ | 360,351 |  |  | 100.0%
(a)Note – This table has been updated to conform to the current year presentation.

X
- Definition Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer. + References No definition available. + Details
Name: | us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration